Alexander R. Moschen

Author

Also Known As

A Moschen, A R Moschen, A. MOSCHEN, A. Moschen, A. R. Moschen, A.R. Moschen, Alexander Moschen, Alexander R Moschen, Alexander R. Moschen, Alexander Rupert Moschen

218

Publications

21.1K

Citations

H-Index

Concepts

All Affiliations

Innsbruck Medical University Universität Innsbruck Christian Doppler Klinik University Hospital Innsbruck Johannes Kepler University of Linz

About

Alexander R. Moschen is an author at Innsbruck Medical University specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	24	3.3K
2	Health Sciences	12	12	1.8K
3	Cell Biology	4	4	344
4	Public Health	2	2	214
5	Biochemistry	1	1	103

Alexander R. Moschen

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties Alexander R. Moschen, Arthur Kaser, Barbara Enrich, The Journal of Immunology	2007	914
Recovery of ethanol-induced <i>Akkermansia muciniphila</i> depletion ameliorates alcoholic liver disease Christoph Grander, Timon E. Adolph, Verena Wieser, Gut	2017	594
Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction Michelle M. Richardson, Julie R. Jonsson, Elizabeth E. Powell, Gastroenterology Metabolic Associated SteatohepatitisFibrosisHepatologyNonalcoholic Fatty Liver DiseaseLiver Physiology	2007	477
Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations Alexander R. Moschen, Romana R. Gerner, Jun Wang, Cell Host & Microbe InflammationDysbiosisMucosal ImmunologyHost-microbe InteractionsGut Microbiology	2016	390
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression Alexander R. Moschen, Clemens Molnar, Sabine Geiger, Gut	2010	271
Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease Lisa Mayr, Felix Grabherr, Julian Schwärzler, Nature Communications	2020	271
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus Stefan Kiechl, Jürgen Wittmann, Andrea Giaccari, Nature Medicine Metabolic SyndromeInsulin SignalingDiabetes ManagementSignal TransductionMedicine	2013	251
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes Peter Willeit, Philipp Skroblin, Alexander R. Moschen, Diabetes	2016	249
IL-37 protects against obesity-induced inflammation and insulin resistance Dov B. Ballak, Janna A. van Diepen, Alexander R. Moschen, Nature Communications ObesityMetabolic SyndromeInflammationInsulin ResistanceImmunology	2014	223
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss Alexander R. Moschen Gut	2005	223

Page 1